Bristol Sees Plavix Free Of Generics Until 2011; First Patent Expires In 2003
Executive Summary
Bristol-Myers Squibb's next patent dispute may involve the antithrombotic Plavix (clopidogrel)
You may also be interested in...
Sanofi/Aventis Merger Would Create Top 10 U.S. Pharma Company
A Sanofi/Aventis merger combination would break Sanofi into the top 10 ranking of U.S. pharmaceutical companies
Sanofi/Aventis Merger Would Create Top 10 U.S. Pharma Company
A Sanofi/Aventis merger combination would break Sanofi into the top 10 ranking of U.S. pharmaceutical companies
Sanofi/Aventis Would Create Oncology Contender: Will Aventis Say “Oui”?
A Sanofi/Aventis combination would create an emerging oncology powerhouse in the U.S